Prevalence of Anti-Insulin, Anti-IA2, Anti-GAD, Anti-IR Auto-antibodies and Anti-Neu5Gc Antibodies in Diabetic Type I And II Patients

Ganou, Christina-Julia/ Petrou, Christos/ Zografou, Ioanna/ Kotsa, Kalliopi/ Varsamidou, Efterpi/ Sampanis, Christos/ Giovos, Ioannis/ Oulorgia, Jensila/ Damontsidou, Katerina/ Eleftheriou, Phaedra/ Zaimi, Terpsithea/ Varsamidis, Konstantinos/ Markou, Helen-Irene/ Γκάνου, Χριστίνα-Τζούλια/ Δαμοντσίδου, Κατερίνα/ Ελευθερίου, Φαίδρα/ Βαρσαμίδης, Κωνσταντίνος/ Μάρκου, Ελένη-Ειρήνη/ Ζαΐμη, Tερψιθέα/ Βαρσαμίδου, Ευτέρπη/ Σαμπάνης, Χρήστος/ Ζωγράφου, Ιωάννα/ Κότσα, Καλλιόπη/ Γιώβος, Ιωάννης/ Πέτρου, Χρήστος


Full metadata record
DC FieldValueLanguage
dc.contributor.authorGanou, Christina-Juliael
dc.contributor.authorPetrou, Christosel
dc.contributor.authorZografou, Ioannael
dc.contributor.authorKotsa, Kalliopiel
dc.contributor.authorVarsamidou, Efterpiel
dc.contributor.authorSampanis, Christosel
dc.contributor.authorGiovos, Ioannisel
dc.contributor.authorOulorgia, Jensilael
dc.contributor.authorDamontsidou, Katerinael
dc.contributor.authorEleftheriou, Phaedrael
dc.contributor.authorZaimi, Terpsitheael
dc.contributor.authorVarsamidis, Konstantinosel
dc.contributor.authorMarkou, Helen-Ireneel
dc.contributor.otherΓκάνου, Χριστίνα-Τζούλιαel
dc.contributor.otherΔαμοντσίδου, Κατερίναel
dc.contributor.otherΕλευθερίου, Φαίδραel
dc.contributor.otherΒαρσαμίδης, Κωνσταντίνοςel
dc.contributor.otherΜάρκου, Ελένη-Ειρήνηel
dc.contributor.otherΖαΐμη, Tερψιθέαel
dc.contributor.otherΒαρσαμίδου, Ευτέρπηel
dc.contributor.otherΣαμπάνης, Χρήστοςel
dc.contributor.otherΖωγράφου, Ιωάνναel
dc.contributor.otherΚότσα, Καλλιόπηel
dc.contributor.otherΓιώβος, Ιωάννηςel
dc.contributor.otherΠέτρου, Χρήστοςel
dc.date.accessioned2015-07-12T15:43:22Zel
dc.date.accessioned2018-02-28T13:48:50Z-
dc.date.available2015-07-12T15:43:22Zel
dc.date.available2018-02-28T13:48:50Z-
dc.date.issued2013el
dc.identifier.citationVarsamidis, K.,Phaerdra,Eleftheriou.,Zaimi,Terpsithea.,Markou,Helen-Irene.,Damontsidou,Ekaterini.,Oulorgia,Jensila.,Varsamidou,Efterpi.,Sampanis,Christos.,Zografou,Ioanna.,Kotsa,Kalliopi.,Giovos,Ioannis.,Petrou,Christos.,Ganou,Christina-Joulia.(2013). Prevalence of Anti-Insulin, Anti-IA2, Anti-GAD, Anti-IR Auto-antibodies and Anti-Neu5Gc Antibodies in Diabetic Type I And II Patients.. Πρακτικά συνεδρίου από 4ο Regional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conference "Technical Advances and Current Practices" που διεξήχθη σε Athens. Φορέας διεξαγωγής Regional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conference. Athens: Regional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conference.el
dc.identifier.citationRegional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conference, Athens, 2013el
dc.identifier.urihttp://195.251.240.227/jspui/handle/123456789/8539-
dc.descriptionΔημοσιεύσεις μελών--ΣΕΥΠ--Τμήμα Φυσικοθεραπείας, 2013el
dc.description.abstractAutoimmunity is a major cause of Diabetes, mainly IDDM. Although, inheritance is recognized, the etiology of the disease is not fully underst ood and environmental factors are believed to be involved. Background : A number of auto - antibodies are developed in diabetes type IA but also in diabetes type II. Since, antibodies are identified before the onset of disease; their measurement has been prop osed as a prognostic tool. Neu5Gc is a sialic acid synthesized by animals but not humans and birds. It can be incorporated in human cells and can trigger immune response. High concentrations of anti - Neu5Gc were detected by our team in diabetic patients, p roposing it as a probable environmental factor. = Objective : Anti - Insulin/anti - IA2/anti - GAD/anti - IR auto - antibodies and anti - Neu5GcIgG/IgM/IgA antibodies were measured in 40 type I and 50 type II patients. A probable correlation between the development of anti - Neu5Gc antibodies and auto - antibodies is investigated and their prognostic value is discussed. Results and Discussion : IgG/IgM/IgA auto - antibodies as well as anti - Neu5Gc antibodies were present in 50% of Diabetic type I patients. 88.9% of auto - antibod y positive samples were also anti - Neu5Gc positive and 90.9% of auto - antibody negative were also anti - Neu5Gc negative. Anti - insulin/anti - IA2/anti - GAD/anti - IR IgG/IgM/IgA were present in 13.8% of Diabetic type II patients, 83% of which were also anti - Neu5Gc positive. Conclusion : The results indicate a correlation between development of auto - antibodies and anti - Neu5Gc and introduce anti - Neu5Gc as a probable prognostic factor of diabetes type Iel
dc.language.isoenel
dc.relation.ispartofRegional European Congress of Biomedical Laboratory Science & the 4th Greek Medical Laboratory Technologists Conferenceel
dc.rightsThis item is probably protected by Copyright Legislationel
dc.rightsΤο τεκμήριο πιθανώς υπόκειται σε σχετική με τα πνευματικά δικαιώματα νομοθεσίαel
dc.subjectAnti-Insulinel
dc.subjectDiabetic typeel
dc.subjectPatientsel
dc.subjectAntibodiesel
dc.titlePrevalence of Anti-Insulin, Anti-IA2, Anti-GAD, Anti-IR Auto-antibodies and Anti-Neu5Gc Antibodies in Diabetic Type I And II Patientsel
dc.typeConference articleel
heal.typeotherel
heal.type.enOtheren
heal.dateAvailable2018-02-28T13:49:50Z-
heal.languageelel
heal.accessfreeel
heal.recordProviderΤΕΙ Θεσσαλονίκηςel
heal.fullTextAvailabilityfalseel
heal.type.elΆλλοel
Appears in Collections:Δημοσιεύσεις σε Συνέδρια

Files in This Item:
There are no files associated with this item.



 Please use this identifier to cite or link to this item:
http://195.251.240.227/jspui/handle/123456789/8539
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.